To evaluate the response rate, response duration, and survival of patients treated with
CC-5013 in a chronic dosing schedule versus a syncopated dosing schedule.
- History of histologically documented multiple myeloma with relapsed or resistant
- Pregnant or nursing women may not participate. Women of childbearing potential must
have a negative pregnancy documented within one week of registration. Women of
reproductive potential may not participate unless they have agreed to use an
effective contraceptive method.
- Signed written informed consent and willingness to meet follow-up schedule and study